Rank;Global Rank;Institution;Country;Sector
1;130;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
2;144;GlaxoSmithKline, United Kingdom;GBR;Companies
3;150;Hoffmann-La Roche Ltd, United States;USA;Companies
4;154;Genentech Inc;USA;Companies
5;179;Boehringer Ingelheim GmbH Germany;DEU;Companies
6;235;AstraZeneca, United States;USA;Companies
7;260;Boehringer Ingelheim, USA;USA;Companies
8;264;Merck & Co Inc, United States;USA;Companies
9;288;GlaxoSmithKline, United States;USA;Companies
10;291;AstraZeneca, Sweden;SWE;Companies
11;346;AstraZeneca, United Kingdom;GBR;Companies
12;547;Novartis Pharmaceuticals, United States;USA;Companies
13;580;Novartis, Switzerland;CHE;Companies
14;625;Regeneron Pharmaceuticals Inc;USA;Companies